Effective | Percentage (%) | Mean ± SD | |
Sex | |||
Male | 40 | 54.8 | |
Feminine | 33 | 45.2 | |
Middle age | 32.18 ± 12.44 | ||
Geographic origin | |||
Urban area | 40 | 54.8 | |
Rural area | 33 | 45.2 | |
Diagnostic delay | 6.8 ± 7.44 | ||
Family history | 35 | 47.9 | |
Spine injury | |||
Cervical involvement | 9 | 12.3 | |
Back injury | 3 | 4.1 | |
Lumbar injury | 68 | 93.1 | |
Buttock pain | 63 | 86.3 | |
Talalgia | 45 | 61.6 | |
Anterior chest pain | 15 | 20.5 | |
Peripheral involvement | 18 | 24.7 | |
History of uveitis (n = 35) | 21 | 28.8 | |
Heart attack | 3 | 4.1 | |
Kidney damage | 9 | 12.3 | |
HLAB27 antigen (n = 42) | 30 | 41.1 | |
BASFI | 4.6 ± 1.29 | ||
BASDAI | 3.93 ± 0.91 |